About Index Trending news
Analyze
Top 50 Pricing
LYSOGENE

LYSOGENE

Work at LYSOGENE? Add yourself to this profile

LYSOGENE

Lysogene is a global leader in the basic research and clinical development of gene therapy for neurodegenerative disorders.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series A)
$22,000,000
Employees

Team size

2
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when LYSOGENE makes some noise.